Tataa Biocenter: Binodh DeSilva, Kaia Sartori, Lydia Michaut, Matthias Machacek, Zain Kassam
Tataa Biocenter, a contract research organization based in Sweden that provides molecular analysis services, has formed a scientific advisory board. The inaugural members of the SAB are Binodh DeSilva, Kaia Sartori, Lydia Michaut, Matthias Machacek, and Zain Kassam.
DeSilva has held leadership roles at Ultragenyx, Bristol-Myers Squibb, and Amgen. She has a PhD in bioanalytical chemistry. Sartori has served as VP of bioanalysis and biomarkers at Amador Bioscience, director of integrated bioanalysis at AstraZeneca, and group leader at PPD. She holds a PhD in medicinal chemistry. Michaut is currently director of scientific governance at Novartis. She holds a PhD in molecular biology and innate immunity. Machacek is the founder and managing director of Lyo-X, a consulting firm based in Switzerland. Prior to that, he led the medicinal engineering group at Novartis. He holds a PhD in fluid dynamics. Kassam is the cofounder and former chief medical officer of Finch Therapeutics and OpenBiome. He holds an MPH in quantitative methods from Harvard University and an MD from Western University.